Indications, techniques and results of percutaneous patent foramen ovale closure

被引：0

作者：

Spies, C. ^{[1
]}

Hijazi, Z. M. ^{[2
]}

机构：

[1] Queens Med Ctr, Dept Cardiovasc Dis, Honolulu, HI USA

[2] Rush Univ, Med Ctr, Rush Ctr Congenital & Struct Heart Dis, Chicago, IL 60612 USA

来源：

MINERVA CARDIOANGIOLOGICA | 2012年 / 60卷 / 01期

关键词：

Foramen ovale; patent; Stroke; Cardiovascular diseases; PRESUMED PARADOXICAL EMBOLISM; ATRIAL SEPTAL-DEFECT; OBSTRUCTIVE SLEEP-APNEA; AMPLATZER PFO OCCLUDER; TO-LEFT SHUNTS; TRANSCATHETER CLOSURE; CRYPTOGENIC STROKE; TRANSCRANIAL DOPPLER; SECONDARY PREVENTION; DEVICE CLOSURE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patent foramen ovale (PFO) has been shown to be more prevalent in certain disease states, suggesting a potentially causative role in some patients with cryptogenic stroke, migraine headache or a number of other conditions. Percutaneous PFO closure has become a reasonable treatment option in a subset of those patients. Our objective is to review the possible indications of PFO closure. We further elucidate the technical aspects of PFO closure, provide an overview of the available devices and summarize results of PFO closure procedures.

引用

收藏

页码：111 / 123

页数：13

相关论文

共 80 条

[71] Late Results After Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism Using the Amplatzer PFO Occluder Without Intraprocedural Echocardiography Effect of Device Size [J].

Wahl, Andreas ;

Tai, Tony ;

Praz, Fabien ;

Schwerzmann, Markus ;

Seiler, Christian ;

Nedeltchev, Krassen ;

Windecker, Stephan ;

Mattle, Heinrich P. ;

Meier, Bernhard .

JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (02) :116-123

[72]

Waight DJ, 2000, CATHETER CARDIO INTE, V50, P195, DOI 10.1002/(SICI)1522-726X(200006)50:2<195::AID-CCD11>3.0.CO

[73]

2-F

[74] Re-evaluation of the relationship between migraine and persistent foramen ovale and other right-to-left shunts [J].

Wilmshurst, P ;

Pearson, M ;

Nightingale, S .

CLINICAL SCIENCE, 2005, 108 (04) :365-367

[75] Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons [J].

Wilmshurst, PT ;

Nightingale, S ;

Walsh, KP ;

Morrison, WL .

LANCET, 2000, 356 (9242) :1648-1651

[76] Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke [J].

Windecker, S ;

Wahl, A ;

Nedeltchev, K ;

Arnold, M ;

Schwerzmann, M ;

Seiler, C ;

Mattle, HP ;

Meier, B .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (04) :750-758

[77] Closure of patent foramen ovale after cryptogenic stroke [J].

Woehrle, Jochen .

LANCET, 2006, 368 (9533) :350-352

[78] Development and testing of the helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system [J].

Zahn, EM ;

Wilson, N ;

Cutright, W ;

Latson, LA .

CIRCULATION, 2001, 104 (06) :711-716

[79] Transcatheter closure of patent foramen ovale with the Spider™ patent foramen ovale occluder: a prospective, single-center trial [J].

Zhang Cao-jin ;

Huang Yi-gao ;

Huang Xin-sheng ;

Huang Tao ;

Huang Wen-hui ;

Shen Jun-jun ;

Xun Zheng-rong .

CHINESE MEDICAL JOURNAL, 2010, 123 (07) :834-837

[80] Patent Foramen Ovale Closure With the SeptRx Device Initial Experience With the First "In-Tunnel" Device [J].

Zimmermann, Wibke J. ;

Heinisch, Corinna ;

Majunke, Nicolas ;

Staubach, Stephan ;

Russell, Scott ;

Wunderlich, Nina ;

Sievert, Horst .

JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (09) :963-967

← 1 2 3 4 5 6 7 8 →